Urgent recall for mushrooms over fears they can cause 'fatal infections'
Enoki mushrooms and a few kinds of sliced mushrooms sold in three states could be tainted with Listeria monocytogenes.
LLK Trading Inc on Sunday recalled 200-gram packages of its Needle Mushrooms, also known as Enoki mushrooms, that were sent to Bally Produce Corp in Maspeth, New York, and sold to Datang Supermarket Inc.
They are in plastic packaging that is clear on the top and blue at the bottom.
The nation's agency responsible for protecting the public health found listeria after doing routine testing of some packages. Product sales have stopped as the US Food and Drug Administration (FDA) and the company investigate how the contamination started.
There have not been any reports of customers becoming sick from eating the Enoki mushrooms, according to the announcement published by the FDA.
Customers should not eat them and return them for a full refund. Anyone with questions is urged to contact the company, which is based in Linden, New Jersey.
And on Friday, Wiet Peeters Farm Products Limited recalled its 227-gram packages of Aunt Mid's Fresh Sliced Mushrooms and Peeters Mushroom Farm Cremini Sliced Mushrooms, and 10-pound cardboard packages of Peeters Mushroom Farm Thick Slice Mushrooms.
Canadian Food Inspection Agency inspectors discovered listeria in the Fresh Sliced Mushrooms packages while testing the item, according to the FDA announcement. The two other products were manufactured on the same line. More Trending
The company based in Charing Cross Ontario, Canada, distributed the mushrooms to Michigan and Ohio. There have not been reports of people becoming ill, and customers with questions should contact Wiet Peeters Farm Products.
Listeria monocytogenes is 'an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems', according to the FDA.
It can cause pregnant women to have miscarriages or stillbirths. Healthy people can experience symptoms including diarrhoea, strong headaches, high fever, abdominal pain, nausea and stiffness.
The recalls come a couple of weeks after pre-made salads sold in eight US stated were recalled because they could contain cucumbers with salmonella.
Get in touch with our news team by emailing us at webnews@metro.co.uk.
For more stories like this, check our news page.
MORE: Teddy bear 'made of human skin' sparks police investigation
MORE: Angry Trump fans burn their MAGA hats over Epstein files mystery
MORE: Trump gives Putin a 50-day deadline to stop war in Ukraine
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Record
4 hours ago
- Daily Record
Scientists make Parkinson's breakthrough with new weekly injectable drug
Scientists have developed a new weekly injectable drug that could transform the lives of more than eight million people living with Parkinson's disease. The new treatment, which helps with muscle tremors, could potentially replace the need for multiple daily tablets, making life simpler and easier for those living with the condition. Scientists from the University of South Australia (UniSA) developed a long-acting injectable formulation that delivers a steady dose of levodopa and carbidopa - two key medications for Parkinson's - to last an entire week. The medication comes in the form of a biodegradable gel that can be injected under the skin or into muscle tissue, where it gradually releases the drugs over a week-long period. Parkinson's disease is the second most common neurological disorder, affecting more than 8.5 million people worldwide. There are approximately 13,000 people living with Parkinson's disease in Scotland, according to Parkinson's UK. Currently there is no cure, and the many symptoms of the condition, including tremors, rigidity and slow movement, are currently managed with pills that must be taken several times a day. But scientists believe the newly developed injection for Parkinson's could revolutionise how the disease is treated, and change the lives of those living with the condition. Lead researcher Professor Sanjay Garg, from UniSA's Centre for Pharmaceutical Innovation, said: "Our goal was to create a formulation that simplifies treatment, improves patient compliance, and maintains consistent therapeutic levels of medication. "This weekly injection could be a game-changer for Parkinson's care. Levodopa is the gold-standard therapy for Parkinson's, but its short life span means it must be taken several times a day." But the new drug can stop the constant hassle of taking multiple pills every day. The jab can maintain consistent plasma levels in the body by slowly releasing both levodopa and carbidopa steadily throughout the week, which also reduces the risks associated with fluctuating drug concentrations. UniSA PhD student Deepa Nakmode said: "After years of focused research, it's incredibly rewarding to see our innovation in long-acting injectables for Parkinson's disease reach this stage. Our invention has now been filed for an Australian patent." The injectable gel combines an FDA-approved biodegradable polymer named PLGA with Eudragit L-100, which is a pH-sensitive polymer. This ensures a controlled and sustained drug release into the body. Prof Garg concluded: "The implications of this research are profound. By reducing the frequency of dosing from multiple times a day to a weekly injection is a major step forward in Parkinson's therapy. "We're not just improving how the drug is delivered; we're improving patients' lives." The scientist says this new technology could also be adapted for other chronic conditions such as cancer, diabetes, neurodegenerative disorders, pain management, and chronic infections.
The Guardian
16 hours ago
- The Guardian
US dairy industry to remove synthetic dyes from ice-cream, RFK Jr says
In what Trump administration officials dubbed a 'major announcement', health and agriculture department leaders said the US dairy industry agreed to voluntarily remove synthetic dyes from ice-cream. The announcement continues the Trump administration's pattern of voluntary agreements with industry – from health insurers to snack food makers. 'This is relevant to my favorite food, which is ice-cream,' said the US health secretary, Robert F Kennedy Jr. 'Since we came in about five and a half months ago and started talking about eliminating dyes and other bad chemicals from our food, we've had this extraordinary response from our industry.' Representatives of the dairy industry said that more than 40 ice-cream companies agreed not to use synthetic dyes. Kennedy also alluded to the future release of new dietary guidelines, which would 'elevate' dairy products, including full-fat dairy, to 'where they ought to be in terms of contributing to the health of our children'. The head of the US Food and Drug Administration (FDA), Dr Marty Makary, also announced that his agency approved a new plant-based dye: 'gardenia blue'. The value of full-fat dairy is an ongoing subject of debate in nutrition research circles. For decades, government health authorities have cautioned against too much saturated fats, sugars and refined grains because of their link to obesity and heart disease. Some high-profile researchers now argue that full-fat dairy may not be as harmful as once thought. That is a perspective shared by the US dairy industry, which has funded nutrition research and fought against government controls on dairy in school lunches since the Obama administration. The issue is also important in rural communities across dairy country, where farmers began displaying hand-painted hay bails outside farms with messages such as: 'Drink whole milk 97% fat free.' The Trump administration has held a close relationship with the dairy industry for years, stretching all the way back to the president's first term. In 2019, then agriculture secretary Sonny Perdue toasted dairy lobbyists with a glass of chocolate milk to celebrate the reintroduction of once-banned flavored milks back into schools. 'This is a great day for dairy and a great day for 'make America healthy again,'' said Michael Dykes, the president and CEO of the International Dairy Foods Association. 'We're so happy with the voluntary industry-led commitment.' Notably, the Trump administration's effort to reach voluntary agreements with industry has also shown the strategy's limits. For instance, Mars, the maker of Skittles and M&M's, resisted Kennedy's efforts. Meanwhile, on health insurance, experts have expressed skepticism that an agreement with private insurers will significantly help Americans.
The Independent
19 hours ago
- The Independent
UN says 14 million children did not receive a single vaccine in 2024
More than 14 million children did not receive a single vaccine last year — about the same number as the year before — according to U.N. health officials. Nine countries accounted for more than half of those unprotected children. In their annual estimate of global vaccine coverage, released Tuesday, the World Health Organization and UNICEF said about 89% of children under one year old got a first dose of the diphtheria, tetanus and whooping cough vaccine in 2024, the same as in 2023. About 85% completed the three-dose series, up from 84% in 2023. Officials acknowledged, however, that the collapse of international aid this year will make it more difficult to reduce the number of unprotected children. In January, U.S. President Trump withdrew the country from the WHO, froze nearly all humanitarian aid and later moved to close the U.S. AID Agency. And last month, Health Secretary Robert F. Kennedy Jr. said it was pulling the billions of dollars the U.S. had previously pledged to the vaccines alliance Gavi, saying the group had 'ignored the science.' Kennedy, a longtime vaccine skeptic, has previously raised questions the diphtheria, tetanus and whooping cough vaccine — which has proven to be safe and effective after years of study and real-world use. Vaccines prevent 3.5 million to 5 million deaths a year, according to U.N. estimates. 'Drastic cuts in aid, coupled with misinformation about the safety of vaccines, threaten to unwind decades of progress,' said WHO Director-General Tedros Adhanom Ghebreyesus. U.N. experts said that access to vaccines remained 'deeply unequal' and that conflict and humanitarian crises quickly unraveled progress; Sudan had the lowest reported coverage against diphtheria, tetanus and whooping cough. The data showed that nine countries accounted for 52% of all children who missed out on immunizations entirely: Nigeria, India, Sudan, Congo, Ethiopia, Indonesia, Yemen, Afghanistan and Angola. WHO and UNICEF said that coverage against measles rose slightly, with 76% of children worldwide receiving both vaccine doses. But experts say measles vaccine rates need to reach 95% to prevent outbreaks of the extremely contagious disease. WHO noted that 60 countries reported big measles outbreaks last year. The U.S. is now having its worst measles outbreak in more than three decades, while the disease has also surged across Europe, with 125,000 cases in 2024 — twice as many as the previous year, according to WHO. Last week, British authorities reported a child died of measles in a Liverpool hospital. Health officials said that despite years of efforts to raise awareness, only about 84% of children in the U.K. are protected. 'It is hugely concerning, but not at all surprising, that we are continuing to see outbreaks of measles,' said Helen Bradford, a professor of children's health at University College London. 'The only way to stop measles spreading is with vaccination,' she said in a statement. 'It is never too late to be vaccinated — even as an adult.' __ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
